LSI Medience, NCC, and NIBIOHN Team Up for National Project to Develop PDX Mice

Hiroyuki Mano, Director of National Cancer Center Research Institute LSI Medience, the National Cancer Center Japan (NCC), and the National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN) will set out to commercialize patient-derived xenograft (PDX) mice, which have tissues...read more